Guofu Hydrogen successfully launched its IPO on the Hong Kong Stock Exchange, marking a significant milestone for the company and its investor, CM Venture, who anticipates substantial returns from this strategic investment.

Information on the Target

Guofu Hydrogen, headquartered in Zhangjiagang, China, is a prominent provider of full-industry-chain solutions for hydrogen equipment. The company has established itself as a leader in the hydrogen market by consistently holding the number one market share in China for five consecutive years in areas such as hydrogen production, storage, transportation, fueling, and utilization equipment manufacturing. With an ambitious plan to issue 6 million shares globally at an indicative offer price of HKD 65 per share, Guofu Hydrogen aims to use the proceeds from its recent IPO to expand its production capacity and enhance its research and development capabilities.

On November 15, 2024, Guofu Hydrogen officially joined the Hong Kong Stock Exchange (HKEX), marking a significant milestone for both the company and its main investor, CM Venture. The stock, with symbol ‘2582’, experienced a notable price increase on its debut day, rising to 86 HKD, reflecting a 32.31% gain shortly after trading commenced.

Industry Overview in China

China's hydrogen industry has been rapidly evolving, driven by the government’s commitment to reducing carbon emissions and transitioning towards clean energy sources. The country is focusing on expanding its hydrogen infr

View Source

Similar Deals

君联资本 重塑能源

2024

Public-to-Private (P2P) Hydrogen Fuel China
君联资本 (Qinlian Capital) 重塑能源 (Reformed Energy)

2024

Public-to-Private (P2P) Hydrogen Fuel China
Qiming Venture Partners LanzaTech Global, Inc.

2023

Public-to-Private (P2P) Renewable Fuels (NEC) China
启明创投 壁仞科技

2026

Public-to-Private (P2P) Processors China
MiniMax Group Inc. MiniMax Group Inc.

2026

Public-to-Private (P2P) Machine Learning & Artificial Intelligence (AI) Services China
磐霖资本 瑞博生物

2026

Public-to-Private (P2P) Proprietary & Advanced Pharmaceuticals China

CM Venture

invested in

Guofu Hydrogen

in 2024

in a Public-to-Private (P2P) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert